Nanomedicine and Life Sciences Companies

Develops enabling nucleic acid-based technology applications, aimed at large biosensor/molecular diagnostics, therapeutics, and energy generation/management markets.

Developer, manufacturer and distributor of innovative sample preparation devices for high sensitive mass spectrometry and liquid chromatography.

The core of the company's product line is their proprietary Diffractive Optics Technology - or dot™ - which combines two proven technologies - the diffraction of light and immobilized capture surfaces - to provide a simple, sensitive, and cost-effective technique for the real-time detection of biomolecular interactions and immunoassays without the use of labels.

Through its diagnostic program, Biophage is developing a biosensor using an innovative nanotechnology. These nanosensors are based on impedance spectroscopy, an enabling technology that can detect and quantify microbial pathogens in real-time. The unique nanosensors will be built from various proprietary technologies already developed by Biophage (biocapture molecule: phages and antibodies) and by the Biotechnology Research Institute-NRC (signal generation and detection).

DiagnoCure has specialized in the development, production and commercialization of molecular diagnostics for the detection and management of cancer

Epocal is implementing an entire blood diagnostic 'laboratory on a chip' in FlexCard™ technology, with some elements are fabricated in media with micrometer or nanometer scale flow channels or pores.

Cell's nano sized technology is a low density emulsion, named LDE, with particles similar to the structure of low-density lipoprotein (LDL) which acquires the apo E while in the plasma, thus becoming capable of targeting and binding to the specific receptors of LDL existing on the surface of cellular membranes.

The company's lead product in development is Amorphous Nano-Hydroxyapaite Powder. Nano-structured hydroxyapatite has several advantages over hydroxyapatite of larger particle size in its use in bone tissue engineering due to its higher surface area and consequently higher reactivity, which offers better cellular response. In addition, nano-sized hydroxyapatite is useful as an effective surface modification agent for binding numerous biological molecules.

Develops novel polymeric, nano-delivery systems for delivery of water-insoluble and poorly bio-available drugs.

The Company's lead product in development is a passive, nano-film Hydroxyapatite (HAp) coating. In parallel, the Company is developing a multi-layer nano-film coating with drug-eluting capabilities to facilitate therapeutics and treatments for localized drug delivery systems.

(Site in French) A bionanotechnology firm that develops portable x-ray devices for cancer therapy.

Protiva's 'SNALP' (for stable nucleic acid-lipid particles) are specialized lipid nanoparticles that fully encapsulate and systemically deliver a variety of nucleic acid molecules such as siRNA, aptamers and plasmid DNA.

Photon activaten nano drug delivery systems.

The company's polymer-based Biotransport™ Nano-Carriers have the ability to solubilize and transport molecules through natural barriers such as the blood-brain barrier.

Tekmira is an emerging leader in the advancement of therapeutic agents based upon Nobel Prize winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi).

Zymeworks' core business focus is to develop a pipeline of enabling industrial enzymes for bio-processing and bio-product manufacturing. Zymeworks' core competency is in molecular simulations.